NEW YORK, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Diversified Holdings and Compass Group Diversified Holdings, LLC (NYSE:CODI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Compass you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/compass-diversified-holdings.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ:FTRE) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certain of the Company's senior executives for potential violations of the federal securities laws.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit.

CALF has been one of the worst-performing small-cap value funds over the last two years. Something had to change, and fortunately, an update to the Index methodology occurred in March. At first glance, the main change was selecting 200 stocks instead of 100, which naturally improved diversification. However, CALF's Index also widened its selection universe from 600 to 2,500 stocks. As a result, CALF functions more like a small/mid-cap ETF compared to dedicated small-cap value peers like IJS, AVUV, SFLO, and USVM.

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153058&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=153057&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 25-cv-00734, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired 3D Systems securities between August 13, 2024 and May 12, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations …

Despite recent underperformance and revenue declines, Sealed Air remains a 'buy' due to compelling valuation and improving profitability from restructuring. Management's cost-cutting program is driving significant bottom-line improvements, with annualized savings of $140–$160 million expected once completed. Shares are attractively priced relative to peers, offering the lowest valuation multiples in the packaging sector despite ongoing operational challenges.

Adobe delivered another strong quarter, beating revenue and EPS estimates, and raised full-year guidance, signaling continued operational strength. AI monetization hasn't reached an inflection point, but progress is clear—Firefly integration and ARR growth show Adobe is moving in the right direction. Valuation remains attractive: Adobe trades well below historical multiples, and my revised price target of $652 implies significant upside from current levels.

Shares of Primo Brands Corporation PRMB have been under pressure following soggy spring weather that dampened bottled water sales across key regions, such as the Northeast and Mid-Atlantic.

The quantum computing theme is certainly in play, with the trend expected to remain strong as companies continue to unlock the technology's powers.

NEW YORK , June 13, 2025 /PRNewswire/ -- Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Compass Diversified Holdings (NYSE: CODI) between May 1, 2024, and May 7, 2025, both dates inclusive (the "Class Period"), of the important July 8, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased Compass securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Forward Air's Q1 2025 results show margin recovery, improved free cash flow, and strong liquidity, despite an adjusted EPS loss and stock price decline. The Omni Logistics acquisition has transformed Forward Air into a global logistics leader, driving revenue growth and operational synergies. Risks include high leverage, integration challenges, and activist pressure for a sale, but robust liquidity and operational improvements support a hold rating, so to Hold the stock.

Today's trading session was rocked by volatility as geopolitical tensions mount between Israel and Iran. Tyler Herriage considers the recent sell-off a dip-buying opportunity and remains bullish long-term on the market.

MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Shamis & Gentile, P.A: To: All persons or entities who purchased or otherwise acquired Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ:TEM) common stock between August 6, 2024 and May 27, 2025, inclusive. You are hereby notified that the class action lawsuit Shouse v.

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=153056&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

NORTH LIBERTY, Iowa, June 13, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Heartland Express, Inc. (Nasdaq: HTLD) announced today the declaration of a regular quarterly cash dividend. The $0.02 per share dividend will be paid on July 3, 2025, to shareholders of record at the close of business on June 23, 2025. We currently estimate that a total of $1.6 million will be paid on the Company's approximate seventy-eight million shares of common stock. This is the Company's eighty-eighth consecutive quarterly cash dividend. With the payment of this dividend, the Company will have paid a total of $558.3 …

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) securities between May 2, 2024, to May 6, 2025, inclusive (the “Class Period”). Vestis investors have until August 8, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN VESTIS CORPORATION (VSTS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE.